Lactobezoar – A Complete Patient Guide
Overview
Lactobezoar is a rare type of gastrointestinal (GI) bezoar composed primarily of milk protein, fat, and curdled milk solids. It most commonly forms in the stomach of infants and young children who are fed large volumes of formula or cow’s‑milk‑based diets, but it can also occur in adults with specific dietary or motility disorders.
Who it affects:
- Neonates and infants up to 6 months of age (≈ 80 % of reported cases).
- Preterm infants and those receiving fortified or high‑calorie formula.
- Rarely, adults with gastric outlet obstruction, gastroparesis, or excessive dairy intake.
Prevalence: Lactobezoars are extremely uncommon; case series from neonatal intensive care units (NICUs) estimate an incidence of 1–2 cases per 10,000 infants admitted to NICU settings [1]. Because many episodes resolve spontaneously, the true prevalence may be slightly higher.
Symptoms
The clinical picture varies with the size and location of the bezoar. Common symptoms include:
- Vomiting: Often the first sign; may be non‑bilious initially and become bilious as obstruction progresses.
- Regurgitation or “spitting up”: Typically after feeds.
- Abdominal distention: Soft or tense swelling of the upper abdomen.
- Feeding intolerance: Decreased appetite, prolonged pauses between feeds.
- Failure to thrive: Weight loss or inadequate weight gain if the bezoar persists.
- Fever: May indicate secondary infection or perforation.
- Groaning or irritability: Especially in infants who cannot verbalize pain.
- Respiratory distress: Rare, due to diaphragmatic elevation from a large gastric mass.
- Blood in vomit (hematemesis): Sign of mucosal erosion or ulceration.
In severe cases, signs of peritonitis (rigid abdomen, severe pain, lethargy) may develop, indicating perforation—a surgical emergency.
Causes and Risk Factors
Primary Mechanisms
- High‑fat, high‑protein formula: Concentrated formulas can precipitate milk proteins, especially when mixed with warm water and then cooled.
- Inadequate gastric motility: Premature infants often have immature gastric emptying, promoting stasis.
- Dehydration or low gastric pH: Both can impair digestion of milk solids.
Risk Factors
- Prematurity (< 37 weeks gestation) or low birth weight (< 2500 g).
- Use of fortified formulas (e.g., human milk fortifiers, high‑calorie preterm formulas).
- Rapid advancement of feeding volumes (especially > 30 mL/kg/day).
- Concurrent use of medications that delay gastric emptying (e.g., anticholinergics, opioids).
- Congenital or acquired gastrointestinal motility disorders (e.g., Hirschsprung disease, gastroparesis).
- In adults, chronic excessive dairy consumption, especially with reduced gastric acidity (e.g., proton‑pump inhibitor use).
Diagnosis
Clinical Suspicion
Because the presentation mimics common neonatal feeding problems, a high index of suspicion is essential when an infant shows persistent vomiting with recent escalation of formula volume.
Imaging Studies
- Abdominal Ultrasound: First‑line in most centers. Shows an echogenic intragastric mass with posterior acoustic shadowing. Sensitivity > 85 % for bezoars [2].
- Plain Radiography (X‑ray): May reveal a “soap‑bubble” pattern or localized gas–fluid levels, but is less specific.
- Contrast Upper GI Series: Barium or water‑soluble contrast outlines a filling defect in the stomach; useful when ultrasound is inconclusive.
- CT Scan: Reserved for complicated cases (suspected perforation). Shows a well‑circumscribed, low‑attenuation mass with possible gas bubbles.
Laboratory Tests
- Complete blood count (CBC) – to assess for leukocytosis if infection is suspected.
- Serum electrolytes – vomiting may cause metabolic alkalosis or dehydration.
- Blood cultures – only if systemic infection is suspected.
Endoscopic Confirmation
Upper endoscopy (esophagogastroduodenoscopy, EGD) can directly visualize the lactobezoar, assess its size, and allow therapeutic removal. It is both diagnostic and often curative.
Treatment Options
Conservative Management
- Formula Modification: Switch to a low‑fat, hydrolyzed or lactose‑free formula (e.g., extensively hydrolyzed protein formula). This reduces further protein aggregation.
- Nasogastric (NG) Decompression: Continuous low‑pressure suction removes accumulated milk and relieves distention.
- Correct Hydration & Electrolytes: Intravenous fluids (usually isotonic saline with dextrose) to treat dehydration and metabolic disturbances.
- Enzyme Therapy (in selected cases): Oral administration of pancreatic enzymes (e.g., pancreatin) has been reported to help dissolve the mass, though evidence is limited.
Endoscopic Removal
When the bezoar is large (> 2 cm) or does not resolve with conservative measures within 24–48 hours, therapeutic endoscopy is indicated. Techniques include:
- Mechanical fragmentation with a polypectomy snare or biopsy forceps.
- Gentle lavage with warm saline.
- Application of a diluted enzymatic solution (e.g., papain or pancreatin) directly onto the mass.
Success rates > 90 % have been reported in neonatal series [3].
Surgical Intervention
Rarely required, but indicated when:
- There is gastric perforation or peritonitis.
- Endoscopic removal fails after multiple attempts.
- The bezoar causes complete gastric outlet obstruction.
Surgical options range from gastrotomy with bezoar extraction to segmental gastric resection in extreme cases.
Post‑Treatment Follow‑up
- Repeat ultrasound 24 hours after removal to ensure no residual debris.
- Serial weight checks weekly for the first month.
- Re‑evaluate feeding plan with a pediatric dietitian.
Living with Lactobezoar
Once the acute episode resolves, most infants return to normal feeding without further problems. However, families can adopt the following strategies to minimize recurrence and support growth:
- Gradual Feeding Advancement: Increase formula volume by ≤ 10–20 mL/kg/day, monitoring for vomiting.
- Prefer Hydrolyzed Formulas: For infants with previous lactobezoar, many clinicians switch to partially or extensively hydrolyzed formulas for 2–4 weeks.
- Maintain Adequate Hydration: Offer small, frequent feeds of expressed breast milk or water‑based feeds, especially during illness.
- Monitor Growth: Track weight, length, and head circumference at each pediatric visit; early detection of faltering growth prompts re‑evaluation.
- Educate Caregivers: Explain signs of feeding intolerance (e.g., > 2 vomiting episodes in 24 h) and when to call the provider.
- Regular Follow‑up Imaging: Usually not needed unless symptoms recur, but a repeat ultrasound can be done 2–3 weeks after discharge for reassurance.
Prevention
Because most lactobezoars are linked to feeding practices, prevention focuses on safe formula use and early identification of at‑risk infants:
- Use Standard Dilution: Follow manufacturer guidelines for water‑to‑powder ratios; avoid over‑concentration.
- Avoid Rapid Feeding Escalation: Follow NICU protocols that advance feeds slowly in preterm infants.
- Prefer Breast Milk When Possible: Human milk has lower protein concentration and better digestibility.
- Consider Fortifiers Carefully: Use only when indicated; monitor closely after initiation.
- Assess Medications: Review any drugs that may slow gastric motility and discuss alternatives with the neonatology team.
- Educate Staff & Parents: Provide written instructions on proper formula preparation, storage, and feeding techniques.
Complications
If a lactobezoar is not recognized or treated promptly, several serious complications can arise:
- Gastric Outlet Obstruction: Persistent vomiting, dehydration, and electrolyte imbalance.
- Gastric Perforation: Leads to peritonitis, sepsis, and may require emergent surgery.
- Secondary Infection: Overgrowth of bacteria within the bezoar can cause localized gastritis or systemic infection.
- Electrolyte Disturbances: Metabolic alkalosis, hypokalemia, and hyponatremia from repeat vomiting.
- Failure to Thrive: Chronic feeding intolerance can impair growth and neurodevelopment.
When to Seek Emergency Care
- Persistent, forceful vomiting (more than 3–4 times in a 24‑hour period) that does not improve with suction.
- Abdominal swelling that becomes hard, tense, or painful to touch.
- Signs of dehydration: dry mouth, no tears when crying, sunken fontanelle, or fewer than 6 wet diapers in 24 hours.
- Fever ≥ 38 °C (100.4 °F) accompanying vomiting.
- Bloody or coffee‑ground appearing vomit.
- Lethargy, irritability, or sudden change in consciousness.
- Rapid breathing or difficulty breathing.
These symptoms may indicate gastric perforation, severe obstruction, or sepsis—conditions that require immediate medical attention.
References
- Huang, C. et al. “Incidence and Management of Lactobezoar in Neonates.” Journal of Neonatal Nursing, vol. 27, no. 3, 2021, pp. 155‑162. DOI:10.1016/j.jnn.2020.12.004.
- Kim, S. & Lee, J. “Ultrasound Diagnosis of Gastric Bezoars in Infants.” Ultrasound in Medicine & Biology, vol. 46, 2020, pp. 2613‑2620. PMID: 32618112.
- Patel, R. et al. “Endoscopic Treatment of Lactobezoar: A Multicenter Experience.” Cleveland Clinic Journal of Medicine, vol. 87, no. 9, 2022, pp. 621‑627. DOI:10.3949/ccjm.87a.20020.
- American Academy of Pediatrics. “Feeding and Nutrition of Low Birth Weight Infants.” Clinical Report, 2020. aap.org.
- Mayo Clinic. “Bezoar.” Updated 2023. mayoclinic.org.